Author:
Jawaid Iqbal Jawaid Iqbal
Abstract
Introduction: Usually chronic infection of hepatitis C virus (HCV) is asymptomatic until present as acute hepatitis, acute liver failure or development of cirrhosis with decompensation. New era of Direct-acting antiviral (DAAs) for HCV has evolved the treatment with good result and tolerability. Early diagnosis and treatment can halt the further disease progression. Methodology: In this cross sectional study, all the patients with HCV positive either acute or chronic hepatitis infection, cirrhoisis with or without decompensation , aged 50 year or above, of either gender, presenting in the outpatient department (OPD) were included. Results: A total of 281 patients were enrolled during the study period. Mean age of the study population was 56.91±7.21years (range: 50–90years) and majority were male (51.6%) and with Child class A 136 (48.4%) followed by child class B 96(34.2%). Majority of patients presented as decompensated cirrhosis and raised transamines 160 (56.9%). Most common complication was variceal bleed 95 (33.8%) followed by ascities 88 (31.3%), pedal edema24 (8.5%). More than half of the patients were not eligible for treatment. Correlation between age and gender with liver stage and comorbids was statically significant (p=0.001). Conclusion: Late diagnosis present with complication with least options of treatment. Chronic hepatitis C is curable disease and should be diagnosed as early as possible. There should be screening at younger age.
Reference15 articles.
1. Chronic hepatitis C virus infection in older adults;High;Clinical Infectious Diseases,2005
2. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets;Spearman;Lancet Gastroenterol Hepatol,2017
3. World Health Organization. Combating hepatitis B and C to reach elimination by 2030: advocacy brief. Geneva: World Health Organization; 2016.
4. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. Geneva: World Health Organization; 2016.
5. Qureshi H, Bile KM, Jooma R, et al. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J. 2010;16 Suppl:S15-S23.